5th International Conference on Digital Health

Last updated Dec 13, 2022

Conference Series LLC ltd with immense pleasure invites all the contributors across the globe to the 5th International Conference on Digital Health during March 22-23, 2023 Singapore City, Singapore.

Thrive by Athenahealth

Jun 10, 2025

Health Care Facilities Innovation Conference

Jun 3, 2024

eHealth Networking, Applications and Services

Aug 31, 2023

Prev Next 1 of 7

Thrive by Athenahealth

Jun 10, 2025

Health Care Facilities Innovation Conference

Jun 3, 2024

eHealth Networking, Applications and Services

Aug 31, 2023

Post Views: 295

Optimize your time and investment by downloading a networking info app for the 41st Annual JP Morgan Health Care Conference

Healthcare and IT Marketing Conference

Leave A Reply

Articles

InnoCare Announces the Acceptance of New Drug Application for Orelabrutinib in Primary Immune Thrombocytopenia in China

2026-05-28T09:22:10Z

BEIJING, May 28, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the...

XL‑protein Launches Spin-Off PASylANTA Therapeutics to Develop Long‑Acting IL‑1Ra Biobetters

2026-05-28T08:00:00Z

Freising, Germany, May 28, 2026 (GLOBE NEWSWIRE) -- XL‑protein GmbH today announced the launch of PASylANTA Therapeutics GmbH, a new Germany-based biotechnology company focused on the development of long‑acting IL‑1 receptor...

Anaveon Reports Clinical Benefit of ANV600 in the EXPAND-1 Phase 1 Clinical Trial at ASCO 2026 and Actively Seeks Partners for its Legacy Oncology Portfolio

2026-05-28T08:00:00Z

BASEL, Switzerland, May 28, 2026 (GLOBE NEWSWIRE) -- Anaveon, a late-stage preclinical biotechnology company focused on reprogramming the immune system for the treatment of autoimmune and inflammatory diseases, today announced...

ViCentra Scales Commercial Manufacturing, Triples Capacity and Strengthens Unit Economics

2026-05-28T07:30:00Z

UTRECHT, The Netherlands, May 28, 2026 (GLOBE NEWSWIRE) -- ViCentra, a European medical device company commercializing the Kaleido insulin patch pump system, today announced that commercial‑scale production of Kaleido consumables,...

Synklino announces first patient dosed in Phase 1 trial of SYN002 for CMV prevention in kidney transplantation

2026-05-28T07:30:00Z

COPENHAGEN, Denmark, May 28, 2026 (GLOBE NEWSWIRE) -- Synklino A/S, a clinical-stage biotechnology company developing a first-in-class, ex vivo therapy to transform kidney transplantation outcomes through better CMV prevention, today...

Theolytics’ Ongoing US Phase 1 OCTOPOD-IP Trial of THEO-260 in Ovarian Cancer to be Presented as a Trial in Progress at ASCO 2026

2026-05-28T07:00:00Z

Oxford UK, May 28th, 2026. Theolytics, a clinical-stage biotechnology company developing next-generation oncolytic immunotherapies, announces that its Phase 1 OCTOPOD-IP clinical trial of THEO-260, a novel oncolytic immunotherapy, given by...

Groundbreaking therapy for advanced heart failure: Outcomes of the BIOVAT-HF clinical trial published in NEJM

2026-05-28T07:00:00Z

Repairon Announces Publication of Clinical Trial Results for Engineered Human Heart Muscle Tissue in the New England Journal of Medicine

Enterome receives U.S. FDA Orphan Drug Designation for EO2463 OncoMimics™ to treat “watch-and-wait” indolent non-Hodgkin lymphoma

2026-05-28T06:00:00Z

Paris, France – 28 May 2026

Trogenix doses first patient in Phase I/II clinical trial of TGX-007 gene therapy for glioblastoma

2026-05-28T06:00:00Z

Edinburgh, UK, 28 May 2026 – Trogenix Ltd (“Trogenix” or the “Company”), a clinical-stage oncology company engineering programmable immunotherapies, today announces that the first patient has been dosed in its...

New late-breaking data reinforces IQIRVO®’s impact on ALP, fatigue and pruritus in PBC

2026-05-28T05:30:00Z

PARIS, FRANCE, 28 MAY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) today announced the presentation of new late-breaking results from the ELATIVE® Phase III trial and two real-world studies at the...

Basilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam

2026-05-28T05:15:00Z

Ad hoc announcement pursuant to Art. 53 LR

VERAXA Biotech Strengthens Financial Position with $27.5 Million Principal Amount Senior Secured Note Financing and $50 Million Share Purchase Agreement

2026-05-28T05:11:15Z

Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease

2026-05-28T05:00:00Z

Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease

argenx to Host Myositis R&D Webinar on June 23, 2026

2026-05-28T05:00:00Z

May 28, 2026Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced it...

Memora Supplement Under Investigation: Effective Brain Booster Formula Against EMF Radiation - Latest Memory Health Report

2026-05-27T23:07:08Z

Bacopa Monnieri, Lion's Mane, and Ginkgo Biloba Cognitive Formula - Ingredients, Side Effects, Complaints, and Refund Policy Explained

BioNature Berberine Claims Evaluated: Premium Berberine AMPK Activator Supplement for Blood Sugar & Metabolism Support

2026-05-27T22:30:00Z

Two-Product Berberine and Chromium Picolinate Protocol for AMPK Support, Insulin Sensitivity, and Healthy Blood Sugar Levels Explained

Gala Health: High-Quality Compounded GLP-1 Weight Loss & Hormone Therapy HRT Support

2026-05-27T21:09:02Z

Compounded Tirzepatide, Semaglutide, and Hormone Replacement Therapy Through Gala GLP-1: Licensed Provider Telehealth Plans Starting at $149/Month for 2026

ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York

2026-05-27T20:30:00Z

SAN DIEGO, May 27, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today announced that chief executive officer Kristin Yarema, Ph.D., will present at the Jefferies...

CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

2026-05-27T20:30:00Z

MINNEAPOLIS, May 27, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular...

Supernus Pharmaceuticals to Participate in June Investor Conferences

2026-05-27T20:30:00Z

ROCKVILLE, Md., May 27, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS)...

Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company’s Strategic Direction and Highly Qualified Nominees

2026-05-27T20:20:00Z

Clarifies DOMA’s Inaccuracies and the Reality of Pacira’ Efforts to Strengthen its Market Position